ODAK Phase 3 clinical trials to start in 2016

ODAK Phase 3 clinical trials to start in 2016

The ODAK Phase III clinical trial is scheduled to start in mid 2016 in various eye hospitals in Europe. The Phase III trial will aim to show that PHMB is effective and safe for the treatment of Acanthamoeba Keratitis and will be conducted in patients. Information relating to this trial will be published on this website as soon as available.